Complement is an important effector arm of the human immune response.
Binding of proteolytic fragments derived from activation of complement
by specific receptors leads to responses as diverse as inflammation,
opsonization, and B-cell activation. The importance of characterizing
the expression and regulation of complement in the CNS is highlighted
by growing evidence that complement plays a significant role in the pa
thogenesis of a variety of neurological diseases, such as multiple scl
erosis and Alzheimer's disease. In vitro studies have demonstrated tha
t astrocytes, the predominant glial cell type in the brain, are capabl
e of expressing or producing a majority of the components of the compl
ement system. Expression of many complement proteins synthesized by as
trocytes is regulated by both pro- and anti-inflammatory cytokines, ma
ny of which are also produced by several cell types in the CNS. In add
ition to astrocytes, ependymal cells, endothelial cells, microglia, an
d neurons have recently been shown to synthesize various complement pr
oteins or express complement receptors on their cell surfaces. Togethe
r, these studies demonstrate that several cell types throughout the br
ain have the potential to express complement and, in many cases, incre
ase expression in response to mediators of the acute phase response. T
hese studies suggest that complement may play a greater role in CNS im
mune responses than previously thought, and pave the way for better un
derstanding of the dynamics of complement expression and regulation in
vivo. Such understanding may lead to therapeutic manipulation of comp
lement host defense functions in a variety of inflammatory and degener
ative diseases in the CNS.